857
Participants
Start Date
June 30, 2005
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Certolizumab Pegol
"Strength and Form: Lyophilized product reconstituted to 1 ml containing 200 mg of Certolizumab Pegol (CZP) given as a subcutaneous injection.~Dosage and Frequency: 400 mg every two weeks for at least 6 months, then 200 mg every two weeks.~Duration: Until end of study."
152, Huntsville
148, San Diego
153, Danbury
133, Ocala
140, Orlando
150, Orlando
145, Sarasota
136, Tampa
157, Coeur d'Alene
155, Springfield
134, Wheaton
151, St Louis
156, Lincoln
135, Charlotte
147, Cleveland
158, Dayton
139, Charleston
137, Austin
143, San Antonio
12, Buenos Aires
14, Capital Federal
1, Capital Federal
9, Capital Federal
8, Ciudad Autonoma de Buenos Aire
11, Córdoba
2, Córdoba
13, Quilmes
7, Rosario
10, San Miguel de Tucumán
6, Santa Fe
18, Malvern
21, Maroochydore
23, Perth
179, Antwerp
199, Liège
177, Merksem
29, Pleven
221, Sofia
28, Sofia
30, Sofia
26, Stara Zagora
43, Newmarket
32, Toronto
39, Toronto
35, Hamilton
36, Kitchener
201, Pointe-Claire
31, Sainte-Foy
203, Winnipeg
190, Santiago
49, Santiago
44, Valdivia
52, Rijeka
56, Brno
57, Ostrava Trebovice
187, Pilsen
55, Prague
60, Prague
61, Prague
58, Uherské Hradiště
62, Zlín
64, Pärnu
65, Tallinn
63, Tartu
68, Hyvinkää
160, Montpellier
71, Budapest
73, Budapest
75, Bupadest
191, Debrecen
76, Miskolc
74, Szolnok
79, Afula
82, Ashkelon
81, Haifa
83, Haifa
78, Ramat Gan
77, Tel Aviv
85, Ẕerifin
86, Riga
88, Riga
92, Alytus
89, Kaunas
91, Klaipėda
93, Panevezys
90, Šiauliai
94, Vilnius
95, Mexicalli
96, Monterrey
103, Auckland
101, Christchurch
100, South Canterbury
192, Tauranga
107, Moscow
113, Moscow
222, Moscow
223, Moscow
224, Moscow
109, Saint Petersburg
111, Saint Petersburg
112, Saint Petersburg
193, Saint Petersburg
110, Yaroslavl
117, Belgrade
118, Belgrade
114, Niška Banja
115, Novi Sad
119, Bratislava
121, Košice
120, Piešťany
122, Piešťany
210, Dnipro
209, Donetsk
216, Donetsk
213, Ivano-Frankivsk
211, Kiev
212, Kiev
215, Kiev
220, Kiev
208, Symferopyl
214, Zaporizhzhya
Lead Sponsor
UCB Pharma
INDUSTRY